Susceptibility mutation for breast and ovarian cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 26, 1998
Grant Date -
N/A
app pub date -
Sep 25, 1995
filing date -
Sep 25, 1995
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A new mutation has been found in the BRCA1 gene. The mutation is a two base pair deletion at nucleotides 3888 and 3889 of the published cDNA sequence of BRCA1 (GENBANK ACCESSION NO:U14680). The invention provides a method for diagnosing persons at risk of developing breast or ovarian cancer. The invention also provides a further tool with which to characterize tumors.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully